Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Bacterial Partnering Deals 2012-2018: Trends, Players and Financials -

Research and Markets
Posted on: 12 Mar 18

The "Global Bacterial Partnering 2012-2018: Deal trends, players and financials" report has been added to's offering.

Global Bacterial Partnering 2012 to 2018 provides the full collection of Bacterial disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Bacterial disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Bacterial deals.

The report presents financial deal terms values for Bacterial deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

Report scope

Global Bacterial Partnering 2012 to 2018 includes:

  • Trends in Bacterial dealmaking in the biopharma industry since 2012
  • Analysis of Bacterial deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Bacterial deal contract documents
  • Comprehensive access to over 3500 Bacterial deal records
  • The leading Bacterial deals by value since 2012
  • Most active Bacterial dealmakers since 2012

Deals and contracts are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Bacterial dealmaking

Chapter 3 - Financial deal terms for Bacterial partnering

Chapter 4 - Leading Bacterial deals and dealmakers

Chapter 5 - Bacterial contract document directory

Chapter 6 - Bacterial dealmaking by therapeutic target

For more information about this report visit

View source version on

Business Wire

Last updated on: 12/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.